|
2023
|
Invention
|
Treatment regimen.
The present invention relates to a novel treatment method for the treatment o... |
|
|
Invention
|
Gepotidacin for use in the treatment of bacterial prostatitis. The present invention relates to m... |
|
|
Invention
|
Il-7 binding proteins and their use in medical therapy.
Provided herein are interleukin 7 (IL-7)... |
|
|
Invention
|
Antigen binding proteins and uses thereof. PlasmodiumPlasmodiumPlasmodium circumsporozoite protei... |
|
|
Invention
|
Combination treatment for cancer.
Disclosed herein is a method of treating cancer, such as multi... |
|
|
Invention
|
Gepotidacin formulation. An oral formulation of, or comprising, granules of active pharmaceutical... |
|
|
Invention
|
Methods for purifying recombinant polypeptides. The present invention is directed to a novel proc... |
|
|
Invention
|
Chemical compounds.
Provided are compounds and pharmaceutical compositions and uses thereof for ... |
|
|
Invention
|
Chemical compounds. vvv1.8 mediated diseases, such as pain and pain-associated diseases, and card... |
|
|
Invention
|
Nitrogen containing condensed 2,3-dihydroquinazolinone compounds as nav1.8 inhibitors. Small mole... |
|
|
Invention
|
Use of tnf-alpha binding proteins and il-7 binding proteins in medical treatment. The present dis... |
|
|
Invention
|
Method for inactivation of sars-cov-2. The invention provides a method for inactivating SARS-CoV-... |
|
|
Invention
|
C-mannoside compounds useful for the treatment of urinary tract infections.
Disclosed herein are... |
|
|
Invention
|
Method for assessing tcr t cell therapy designed to target an ny-eso-1 antigen. This document pro... |
|
|
Invention
|
Novel processes for the production of polynucleotides including oligonucleotides. The invention r... |
|
|
Invention
|
Pyrrol derivatives as inhibitors of apolipoprotein l-1. This invention relates to novel compounds... |
|
|
Invention
|
Method of treating chronic hepatitis b. The present disclosure is related to methods for treating... |
|
|
Invention
|
2,4-dioxotetrahydropyrimidinyl derivatives as degrons in protacs. The present invention provides ... |
|
|
Invention
|
Cytotoxicity targeting chimeras for c-c chemokine receptor 2-expressing cells. The present disclo... |
|
|
Invention
|
Cytotoxicity targeting chimeras for prostate specific membrane antigen-expressing cells. The pres... |
|
|
Invention
|
Cytotoxicity targeting chimeras for fibroblast activation protein-expressing cells. The present d... |
|
|
Invention
|
Cytotoxicity targeting chimeras for ccr2-expressing cells. The present disclosure relates to hete... |
|
|
Invention
|
Cytotoxicity targeting chimeras for cxcr3-expressing cells. The present disclosure relates to het... |
|
|
Invention
|
Cytotoxicity targeting chimeras for integrin avb6-expressing cells. The present disclosure relate... |
|
|
Invention
|
Cytotoxicity targeting chimeras for folate receptor-expressing cells. The present disclosure rela... |
|
|
Invention
|
Compounds. The invention relates to compounds or pharmaceutically acceptable salts thereof, compo... |
|
|
Invention
|
Combination therapy for b-cell disorders. This disclosure provides combination therapies comprisi... |
|
|
Invention
|
Mitigating ocular toxicity. Aspects of the disclosure are directed to mitigating ocular toxicity ... |
|
|
Invention
|
High-throughput assay for cell migration, chemotaxis, and function. An assay system permits study... |
|
|
Invention
|
Combination therapy for treating hepatitis b virus infections. The present disclosure is related ... |
|
|
Invention
|
Combination therapy for cancer. This disclosure provides combination therapies comprising an anti... |
|
|
Invention
|
Antigen binding proteins.
This application discloses antigen binding proteins that bind Lymphocy... |
|
|
Invention
|
Gepotidacin and vancomycin for use in the treatment of an infection caused by staphylococcus sapr... |
|
|
Invention
|
Antigen binding proteins.
Antigen binding proteins that bind Lymphocyte Activation Gene 3 (LAG-3... |
|
2022
|
Invention
|
Chemical compounds.
The invention is directed to substituted piperidine derivatives. Specificall... |
|
|
Invention
|
Interleukin 5 binding protein dosage regimen for use in treating polyangiitis, hypereosinophilic ... |
|
|
Invention
|
Pyrazine compounds useful in the treatment of parasitic protozoal infection. Plasmodium falciparu... |
|
|
Invention
|
Carboxyesterase biocatalysts.
The present disclosure provides engineered carboxyesterase enzymes... |
|
|
Invention
|
Chimeric antigen receptors targeting claudin-3 and methods for treating cancer.
Chimeric antigen... |
|
|
Invention
|
Antigen binding proteins.
The present disclosure relates to compositions for treating CD96 media... |
|
|
Invention
|
Compounds useful in hiv therapy.
The invention relates to compounds of Formula (I), (Ia), (Ib), ... |
|
2021
|
Invention
|
Interleukin 5 binding protein dosage regimen.
The present disclosure relates to pharmaceutical c... |
|
|
Invention
|
Nitrogen containing 2,3-dihydroquinazolinone compounds as nav1.8 inhibitors.
Compounds of formul... |
|
|
Invention
|
Imidazonaphthyridines and imidazopyridopyrimidines as ifnar2 agonists for treating sars-cov-2 inf... |
|
|
Invention
|
Antigen binding protein.
Provided herein are antigen binding proteins that specifically bind to ... |
|
|
Invention
|
Crystalline forms of gepotidacin.
Disclosed are novel crystalline forms of gepotidacin and pharm... |
|
|
Invention
|
Cathepsin inhibitors for preventing or treating viral infections.
Provided are cathepsin inhibit... |
|
|
Invention
|
Method for detecting polysorbates.
The present invention relates to provision of a method for de... |
|
2020
|
Invention
|
Il1rap binding proteins.
The present invention relates generally to antibodies in the treatment ... |
|
2018
|
Invention
|
Heterocyclic amides as kinase inhibitors.
Disclosed are compounds having the formula (I) wherein... |
|
2002
|
G/S
|
Pharmaceutical, veterinary and sanitary products; dietetic
substances for medical use, food for ... |
|
2000
|
G/S
|
Pharmaceutical products and specialties acting on the
central nervous system. |
